Genetics and therapy for pediatric eye diseases
- PMID: 33975254
- PMCID: PMC8122153
- DOI: 10.1016/j.ebiom.2021.103360
Genetics and therapy for pediatric eye diseases
Abstract
Ocular morphogenesis in vertebrates is a highly organized process, orchestrated largely by intrinsic genetic programs that exhibit stringent spatiotemporal control. Alternations in these genetic instructions can lead to hereditary or nonhereditary congenital disorders, a major cause of childhood visual impairment, and contribute to common late-onset blinding diseases. Currently, limited treatment options exist for clinical phenotypes involving eye development. This review summarizes recent advances in our understanding of early-onset ocular disorders and highlights genetic complexities in development and diseases, specifically focusing on coloboma, congenital glaucoma and Leber congenital amaurosis. We also discuss innovative paradigms for potential therapeutic modalities.
Keywords: Congenital disorders; Eye organogenesis; Ocular diseases; Retinal development; Therapy; Vision impairment.
Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest All authors declare that they have no competing interests.
Figures
References
-
- Graw J. Eye development. Curr Top Dev Biol. 2010;90:343–386. - PubMed
-
- Cardozo MJ, Almuedo-Castillo M, Bovolenta P. Patterning the vertebrate retina with morphogenetic signaling pathways. Neuroscientist. 2020;26(2):185–196. - PubMed
-
- Miesfeld JB, Brown NL. Eye organogenesis: a hierarchical view of ocular development. Curr Top Dev Biol. 2019;132:351–393. - PubMed
-
- Ohuchi H, Sato K, Habuta M, Fujita H, Bando T. Congenital eye anomalies: more mosaic than thought? Congenit Anom (Kyoto) 2019;59(3):56–73. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
